Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Study data from Emory University, Department of Cell Biology provide new insights into breast cancer therapy
February 1st, 2007
Researchers detail in "Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice," new data in breast cancer. According to a study from the United States, "Following surgery, the hormone dependence of breast tumors is exploited for therapy using antagonists such as tamoxifen, although occasional hormone-resistant clones do appear. Another chemotherapeutic strategy uses microtubule inhibitors such as taxanes." "Unfortunately, these agents elicit toxicities such as leukocytopenia, diarrhea, alopecia, and peripheral neuropathies and are also associated with the emergence of drug resistance. We have previously described a...
Source: Women's Health Weekly (2007-02-01)
|
